Tag: MPOX VACCINE

Rampant Sexual Networks Hinder Mpox Response in Africa

Michael Gwarisa

By Michael Gwarisa Efforts to curb the spread of Mpox among African Union member states remain a challenge due to widespread and interconnected sexual networks, HealthTimes has learned. Uganda currently leads in new Mpox cases, accounting for 50% of all recorded infections in Africa over the past six weeks. The majority of cases in Uganda stem from the Clade 1B strain, which is sexually transmitted. Uganda, Burundi, and the Democratic Republic of Congo (DRC) have collectively recorded 94% of confirmed cases since the beginning of the year. Speaking during the…

Read More

Africa CDC Confirms Mpox Vaccine Production to Start in 2025

Michael Gwarisa

By Michael Gwarisa The Director-General of the Africa Centre for Disease Control (Africa CDC), Dr. Jean Kaseya, told a media briefing that local production of the Mpox vaccine on the continent will commence this year, although he did not provide specific timelines. In 2024, Africa CDC partnered with Bavarian Nordic to enhance vaccine manufacturing capabilities within Africa. The partnership aims to strengthen health security across the continent. We have the outcome; we have now started discussions with the successful bidders,” said Dr. Kaseya. “At the moment, we are finalizing some…

Read More